Salomé Lalvée

1.4k citations

25 papers · 1.0k indexed · 1 hit paper · h-index 12

Oncology top 5%
- Cancer Cells and Metastasis 8
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 6
Cancer Research top 5%
- Cancer Genomics and Diagnostics 13
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations 16
- Lung Cancer Diagnosis and Treatment 6
Immunology
Pathology and Forensic Medicine
Ophthalmology
- Ocular Oncology and Treatments 3
Radiology, Nuclear Medicine and Imaging
- Radiomics and Machine Learning in Medical Imaging 2

Co-authors: Paul Hofman Marius Ilié Véronique Hofman Charles‐Hugo Marquette Élodie Long-Mira Catherine Butori Coraline Bence M. Poudenx
Cited by: Oncology Cancer Research Pulmonary and Respiratory Medicine
Journals: Cancer Research (1 paper)International Journal of Molecular Sciences (1 paper)Annals of Oncology (3 papers)
Partner nations: France United States Portugal

In The Last Decade

Salomé Lalvée

24 papers receiving 1.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Salomé Lalvée

Since Specialization

Citations

This map shows the geographic impact of Salomé Lalvée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salomé Lalvée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salomé Lalvée more than expected).

Fields of papers citing papers by Salomé Lalvée

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salomé Lalvée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salomé Lalvée. The network helps show where Salomé Lalvée may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Salomé Lalvée, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Salomé Lalvée Line = papers co-authored together Salomé Lalvée links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non–Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging The American Journal of Surgical Pathology ·Christophe Bontoux,Véronique Hofman,Emmanuel Chamorey,Renaud Schiappa,Sandra Lassalle,Élodie Long-Mira,Katia Zahaf,Salomé Lalvée,Julien Fayada,Christelle Bonnetaud,Samantha Goffinet,Marius Ilié,Paul Hofman	2024	1
2	Shifting from Immunohistochemistry to Screen for ALK Rearrangements: Real-World Experience in a Large Single-Center Cohort of Patients with Non-Small-Cell Lung Cancer Cancers ·Marius Ilié,Samantha Goffinet,Guylène Rignol,Virginie Lespinet‐Fabre,Salomé Lalvée,Olivier Bordone,Katia Zahaf,Christelle Bonnetaud,Kevin Washetine,Sandra Lassalle,Élodie Long-Mira,Simon Heeke,Véronique Hofman,Paul Hofman	2024	5
3	Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort Pathology ·Nuno Jorge Lamas,Sandra Lassalle,Arnaud Martel,Sacha Nahon‐Estève,Adam Macocco,Katia Zahaf,Salomé Lalvée,Julien Fayada,Virginie Lespinet‐Fabre,Olivier Bordone,Florence Pédeutour,Stéphanie Baillif,Paul Hofman	2023	7
4	Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice International Journal of Molecular Sciences ·Arnaud Martel,Baharia Mograbi,Barnabé Roméo,Lauris Gastaud,Salomé Lalvée,Katia Zahaf,Julien Fayada,Sacha Nahon‐Estève,Christelle Bonnetaud,Myriam Salah,Virginie Tanga,Stéphanie Baillif,Corine Bertolotto,Sandra Lassalle,Paul Hofman	2023	6
5	Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer Journal of Visualized Experiments ·Christophe Bontoux,Virginie Lespinet‐Fabre,Olivier Bordone,Virginie Tanga,Maryline Allégra,Myriam Salah,Salomé Lalvée,Samantha Goffinet,Jonathan Benzaquen,Charles‐Hugo Marquette,Marius Ilié,Véronique Hofman,Paul Hofman	2023	2
6	Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank Cancers ·Arnaud Martel,Lauris Gastaud,Christelle Bonnetaud,Sacha Nahon‐Estève,Kevin Washetine,Olivier Bordone,Myriam Salah,Virginie Tanga,Julien Fayada,Virginie Lespinet,Maryline Allégra,Salomé Lalvée,Katia Zahaf,Stéphanie Baillif,Corine Bertolotto,Baharia Mograbi,Sandra Lassalle,Paul Hofman	2023	2
7	c-Met immunohistochemistry as reflex test at diagnosis for non-small cell lung cancer: a real-world experience from a monocentric case series Journal of Clinical Pathology ·Christophe Bontoux,Véronique Hofman,Milissa Abboute,Virginie Lespinet‐Fabre,Salomé Lalvée,Samantha Goffinet,Olivier Bordone,Élodie Long-Mira,Sandra Lassalle,Florent Murcy,Guylène Rignol,Simon Heeke,Marius Ilié,Paul Hofman	2023	0
8	Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples Lung Cancer ·Marius Ilié,Véronique Hofman,Christophe Bontoux,Samantha Goffinet,Jonathan Benzaquen,Simon Heeke,Jacques Boutros,Sandra Lassalle,Élodie Long-Mira,Katia Zahaf,Salomé Lalvée,Virginie Lespinet‐Fabre,Olivier Bordone,Virginie Tanga,Abel Gómez-Caro,Charlotte Cohen,Jean‐Philippe Berthet,Charles‐Hugo Marquette,Paul Hofman	2023	5
9	Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France) Cancers ·Marius Ilié,Véronique Hofman,Christophe Bontoux,Simon Heeke,Virginie Lespinet‐Fabre,Olivier Bordone,Sandra Lassalle,Salomé Lalvée,Virginie Tanga,Maryline Allégra,Myriam Salah,Doriane Bohly,Jonathan Benzaquen,Charles‐Hugo Marquette,Élodie Long-Mira,Paul Hofman	2022	21
10	Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer Lung Cancer ·Marius Ilié,Mélanie Beaulande,Élodie Long-Mira,Christophe Bontoux,Katia Zahaf,Salomé Lalvée,Marame Hamila,Jonathan Benzaquen,Charlotte Cohen,Jean‐Philippe Berthet,Charles‐Hugo Marquette,Sandra Lassalle,Véronique Hofman,Paul Hofman	2022	11
11	Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France) Cancers ·Sandra Lassalle,Véronique Hofman,Simon Heeke,Jonathan Benzaquen,Élodie Long-Mira,M. Poudenx,Elisabeth Lantéri,Jacques Boutros,Virginie Tanga,Katia Zahaf,Salomé Lalvée,Virginie Lespinet,Olivier Bordone,Jean-Marc Félix,Christelle Bonnetaud,Charles‐Hugo Marquette,Marius Ilié,Paul Hofman	2020	17
12	Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution Journal of Translational Medicine ·Simon Heeke,Véronique Hofman,Marius Ilié,Maryline Allégra,Virginie Lespinet,Olivier Bordone,Jonathan Benzaquen,Jacques Boutros,M. Poudenx,Salomé Lalvée,Virginie Tanga,Carole Salacroup,Christelle Bonnetaud,Charles‐Hugo Marquette,Paul Hofman	2020	9
13	In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients Cancers ·Simon Heeke,Jonathan Benzaquen,Élodie Long-Mira,Benoît Audelan,Virginie Lespinet,Olivier Bordone,Salomé Lalvée,Katia Zahaf,M. Poudenx,Olivier Humbert,Henri Montaudié,Pierre-Michel Dugourd,Madleen Chassang,Thierry Passeron,Hervé Delingette,Charles‐Hugo Marquette,Véronique Hofman,Albrecht Stenzinger,Marius Ilié,Paul Hofman	2019	26
14	Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors Journal of Thoracic Disease ·Léa Berland,Simon Heeke,Olivier Humbert,Adam Macocco,Élodie Long-Mira,Sandra Lassalle,Virginie Lespinet‐Fabre,Salomé Lalvée,Olivier Bordone,Charlotte Cohen,Sylvie Leroy,Véronique Hofman,Paul Hofman,Marius Ilié	2019	60
15	Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients Cancers ·Simon Heeke,Véronique Hofman,Élodie Long-Mira,Virginie Lespinet,Salomé Lalvée,Olivier Bordone,Camille Ribeyre,Virginie Tanga,Jonathan Benzaquen,Sylvie Leroy,Charlotte Cohen,Jérôme Mouroux,Charles‐Hugo Marquette,Marius Ilié,Paul Hofman	2018	9
16	Use of circulating tumor cells in prospective clinical trials for NSCLC patients – standardization of the pre-analytical conditions Clinical Chemistry and Laboratory Medicine (CCLM) ·Marius Ilié,Véronique Hofman,Sylvie Leroy,Charlotte Cohen,Simon Heeke,Florian Cattet,Coraline Bence,Salomé Lalvée,Jérôme Mouroux,Charles‐Hugo Marquette,Paul Hofman	2018	19
17	Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer Annals of Oncology ·Marius Ilié,Edith Szafer‐Glusman,Véronique Hofman,Emmanuel Chamorey,Salomé Lalvée,Éric Selva,Sylvie Leroy,Charles‐Hugo Marquette,Marcin Kowanetz,P. Hedge,Elizabeth A. Punnoose,Paul Hofman	2017	153
18	Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategiesbreakdown → Annals of Oncology ·Marius Ilié,Élodie Long-Mira,Coraline Bence,Catherine Butori,Sandra Lassalle,L. Bouhlel,Laetitia Fazzalari,Katia Zahaf,Salomé Lalvée,Kevin Washetine,Jérôme Mouroux,Nicolas Vénissac,M. Poudenx,Josiane Otto,Jean‐Christophe Sabourin,Charles‐Hugo Marquette,Véronique Hofman,Paul Hofman	2015	459
19	Immunohistochimie et médecine personnalisée en oncologie pulmonaire: potentialités et limites Bulletin du Cancer ·Véronique Hofman,Marius Ilié,Élodie Long-Mira,Sandra Lassalle,Catherine Butori,Coraline Bence,Kevin Washetine,Salomé Lalvée,Paul Hofman	2014	10
20	Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK ‘borderline’-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies Annals of Oncology ·Marius Ilié,Coraline Bence,Véronique Hofman,Élodie Long-Mira,Catherine Butori,L. Bouhlel,Salomé Lalvée,Jérôme Mouroux,M. Poudenx,Josiane Otto,Charles‐Hugo Marquette,Paul Hofman	2014	86

About Salomé Lalvée

Salomé Lalvée is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Cancer Genomics and Diagnostics (13 papers), Cancer Cells and Metastasis (8 papers), Lung Cancer Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (6 papers), Ocular Oncology and Treatments (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Oncology (792 citations), Cancer Research (403 citations) and Pulmonary and Respiratory Medicine (569 citations). Salomé Lalvée has collaborated with scholars based in France, United States and Portugal. Frequent co-authors include Paul Hofman, Marius Ilié, Véronique Hofman, Charles‐Hugo Marquette, Élodie Long-Mira, Catherine Butori, Coraline Bence, M. Poudenx, Sandra Lassalle and Jérôme Mouroux. Their work appears in journals such as Cancer Research, International Journal of Molecular Sciences and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact